Hong Kong SAR

China Minmetal’s wholly-owned subsidiary, Onfem Finance, has returned to the market for a HK$4bn ($511m) refinancing loan at tighter levels than its last syndication.

Bank of Shanghai has launched its first sole mandated international loan into general syndication.

Road King Infrastructure returned to the dollar market for the fourth time this year on Monday. The borrower, which has favoured fixed-for-life perpetual bonds before, offered investors a slightly different perpetual deal this time that would see its coupon be reset but has no additional step-up.

The Securities and Futures Commission of Hong Kong has fined UBS HK$400m ($51m) for overcharging its clients over a 10-year period — in the latest penalty to hit the Swiss bank in the city.

South African mining company Heaven-Sent Gold Group Co has hit the road to drum up demand from investors for its Hong Kong listing, which could be worth up to HK$1.4bn ($179.8m).

Chinese biotechnological company Venus Medtech (Hangzhou) is set to launch its Hong Kong IPO, having lined up an international syndicate to run the deal.

Chinese infant milk formula maker Feihe has raised HK$6.7bn ($856m) from its Hong Kong IPO. Investors put in enough orders to cover the deal by multiple times at the bottom of guidance.

Sun Hung Kai & Co raised $350m from a new bond that exceeded its size expectation, helping support a tender offer.

Biopharmaceutical firm SinoMab BioScience has priced its Hong Kong listing at the bottom of guidance to raise HK$1.4bn ($178.6m), finding support from global long-only funds on the last day of bookbuilding.

Cigarette packaging printer Amvig Holdings has returned to the loan market for a HK$1.15bn ($147m) one year facility to refinance a 2017 borrowing.

Hong Kong-listed United Laboratories International Holdings has increased its borrowing to HK$1.8bn ($230m) after attracting six participants during syndication.

China Construction Bank’s Singapore branch joined the offshore renminbi bond issuance party on Monday with a Rmb1bn ($142m) two year deal.